Cangrelor Decreases Ischemia Driven Revascularization in Patients Undergoing Percutaneous Coronary Intervention: Evidence From a Meta-analysis of Randomized Trials

被引：0
|
作者：
Nairooz, Ramez [1 ]
Sardar, Partha [1 ]
Chatterjee, Suarav [2 ,3 ]
Mushiyev, Savi [1 ]
Pekler, Gerald [1 ]
Visco, Ferdinand [1 ]
机构：
[1] New York Metropolitan Hosp Cntr, New York, NY USA
[2] Brown Univ, Providence, RI 02912 USA
[3] Providence VA Med Ctr, Providence, RI USA
来源：
CIRCULATION | 2013年 / 128卷 / 22期
关键词：
Platelet receptor blockers; Acute coronary syndromes; Percutaneous coronary Intervention;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
12336
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Is aspiration thrombectomy beneficial in patients undergoing primary percutaneous coronary intervention? An updated meta-analysis of randomized trials
    Elgendy, Islam Y.
    Huo, Tianyao
    Bhatt, Deepak L.
    Bavry, Anthony A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B88 - B89
  • [12] Improved clinical outcome with eptifibatide in patients undergoing percutaneous coronary intervention: a meta-analysis of four randomized trials
    Patti, G.
    Pasceri, V.
    Nusca, A.
    D'ambrosio, A.
    Di Sciascio, G.
    EUROPEAN HEART JOURNAL, 2008, 29 : 329 - 330
  • [13] Efficacy and Safety of Ticagrelor in Diabetes Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials
    Zhang, Zeyi
    Chen, Ou
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 77 (05) : 536 - 543
  • [14] Prasugrel versus clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials
    张步春
    车文良
    刘伟静
    徐亚伟
    South China Journal of Cardiology, 2010, 11 (04) : 238 - 245
  • [15] Prasugrel versus ticagrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention; a meta-analysis of randomized controlled trials
    Rodriguez, Z.
    Valdecanas, A.
    Palileo, N.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1465 - 1465
  • [16] Beneficial impact Of cilostazol on restenosis and target vessel revascularization after percutaneous coronary intervention: Evidence from a meta-analysis of randomized clinical trials
    Zoccai, Giuseppe Biondi
    Moretti, Claudio
    Lotrionte, Marzia
    Abbate, Antonio
    Agostoni, Pierfrancesco
    Omede, Pierluigi
    Sciuto, Filippo
    Vetrovec, George W.
    Trevi, Gian Paolo
    Sheiban, Imad
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A): : 188L - 188L
  • [17] Benefits of laboratory personalized antiplatelet therapy in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials
    Zhang, Yong
    Zhang, Pei
    Li, Zhan
    Du, Juanjuan
    Wang, Jiangrong
    Tian, Xiuqing
    Gao, Mei
    Hou, Yinglong
    CARDIOLOGY JOURNAL, 2018, 25 (01) : 128 - 141
  • [18] Efficacy and safety of bivalirudin versus heparin in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials
    Zhang, Shuo
    Gao, Weihua
    Li, Haixia
    Zou, Meijuan
    Sun, Sihao
    Ba, Yijie
    Liu, Yang
    Cheng, Gang
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 209 : 87 - 95
  • [19] Bivalirudin versus Heparin in Women undergoing Percutaneous Coronary Intervention: A Meta-analysis of Randomized Clinical Trials
    Saad, Marwan
    Gamal, Amgad
    Nairooz, Ramez
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (18) : B85 - B85
  • [20] Percutaneous mechanical circulatory support devices in high-risk patients undergoing percutaneous coronary intervention A meta-analysis of randomized trials
    Shi, Wenhai
    Wang, Wuwan
    Wang, Kechun
    Huang, Wei
    MEDICINE, 2019, 98 (37)
12345